Expedia vs XPO
EXPE and XPO side by side, both in transportation services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXPE and XPO compare
Expedia is the larger company, worth 1.6 times as much as XPO ($34.3B against $21.4B).
On earnings, Expedia is cheaper: it trades at 17.8× trailing earnings, against 43.1× for XPO.
Expedia grew revenue faster over the last twelve months (12.0% versus 9.5% for XPO).
Expedia keeps more of each dollar of sales as profit, with a net margin of 13.0% compared with 5.7% at XPO.
Expedia pays a dividend yielding 0.64%; XPO does not pay one.
Expedia scores higher on the StockData Score (17 against 11 for XPO), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXPE | XPO |
|---|---|---|
| Size and price | ||
| Market cap | $34.3B | $21.4B |
| Share price | $285.93 | $183.01 |
| Change, 1 year | 30.1% | 48.0% |
| Change, 5 years | 57.0% | 133% |
| Beta (5Y) | 1.42 | 1.63 |
| Employees | 16K | 37K |
| StockData Score | ||
| Total score | 17 (better) | 11 |
| Valuation score | 3 (better) | 1 |
| Growth score | 4 (better) | 1 |
| Performance score | 4 | 6 (better) |
| Health score | 3 | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 17.8× (better) | 43.1× |
| P/S | 2.2× (better) | 2.4× |
| P/B | 28.4× | 10.9× (better) |
| EV/EBITDA | 9.6× (better) | 17.8× |
| P/FCF | 7.7× (better) | 32.6× |
| PEG | 0.27 | – |
| FCF yield | 13.0% (better) | 3.1% |
| Fair value | $316.85 | $138.31 |
| Margin of safety | 9.8% (better) | −32.3% |
| Growth | ||
| Revenue growth (TTM) | 12.0% (better) | 9.5% |
| Revenue growth, 5Y average | 23.2% (better) | 5.7% |
| Net income growth (TTM) | 82.9% (better) | 51.5% |
| EPS growth (TTM) | 96.6% (better) | 52.9% |
| EPS growth, 5Y average | – | 24.9% |
| Profitability | ||
| Gross margin | 90.4% | – |
| Operating margin | 16.0% (better) | 9.9% |
| Net margin | 13.0% (better) | 5.7% |
| FCF margin | 28.4% (better) | 7.4% |
| Return on equity | 199% (better) | 26.5% |
| Return on invested capital | – | 13.9% |
| Financial health | ||
| Debt / equity | 4.52 | 1.52 (better) |
| Net debt / EBITDA | −0.49 | 2.02 (better) |
| Interest coverage | 7.1× (better) | 4.2× |
| Current ratio | 0.80 | 0.99 (better) |
| Altman Z-score | 1.55 | 3.66 (better) |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.64% | – |
| Payout ratio | 10.5% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 36.3% | – |
| Buyback yield | 5.6% (better) | 1.5% |
| Shareholder yield | 6.2% (better) | 1.5% |
| Ownership | ||
| Held by institutions | 100% | 101% |
| Held by insiders | 9.1% | 3.4% |
| Insider net buying, 12 months | −$8.5M | −$2.1M (better) |
| Superinvestors holding | 1 | 2 (better) |
| Short interest, % of float | 7.3% | 6.2% |
Go deeper
- EXPE stock overview
- EXPE income statement
- EXPE valuation and score
- XPO stock overview
- XPO income statement
- XPO valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.